1. A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study. Issue 2 (1st February 2019) Authors: Gamucci, Teresa; Pizzuti, Laura; Natoli, Clara; Mentuccia, Lucia; Sperduti, Isabella; Barba, Maddalena; Sergi, Domenico; Iezzi, Laura; Maugeri-Saccà, Marcello; Vaccaro, Angela; Magnolfi, Emanuela; Gelibter, Alain; Barchiesi, Giacomo; Magri, Valentina; D'Onofrio, Loretta; Cassano, Alessandra; Ross... Journal: Cancer biology & therapy Issue: Volume 20:Issue 2(2019) Page Start: 192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real‐world evidence. Issue 11 (15th January 2020) Authors: Krasniqi, Eriseld; Pizzuti, Laura; Barchiesi, Giacomo; Sergi, Domenico; Carpano, Silvia; Botti, Claudio; Kayal, Ramy; Sanguineti, Giuseppe; Marchetti, Paolo; Botticelli, Andrea; Marinelli, Daniele; Gamucci, Teresa; Natoli, Clara; Grassadonia, Antonino; Tinari, Nicola; Tomao, Silverio; Tonini, Giu... Journal: Journal of cellular physiology Issue: Volume 235:Issue 11(2020:Nov.) Page Start: 7900 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor‐positive, advanced breast cancer: A real‐world experience. Issue 6 (10th December 2018) Authors: Pizzuti, Laura; Giordano, Antonio; Michelotti, Andrea; Mazzotta, Marco; Natoli, Clara; Gamucci, Teresa; De Angelis, Claudia; Landucci, Elisabetta; Diodati, Lucrezia; Iezzi, Laura; Mentuccia, Lucia; Fabbri, Agnese; Barba, Maddalena; Sanguineti, Giuseppe; Marchetti, Paolo; Tomao, Silverio; Mariani,... Journal: Journal of cellular physiology Issue: Volume 234:Issue 6(2019:Jun.) Page Start: 7708 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗